Perhaps our patients' Jak2 mutation potentially allowed for increased proliferation and stability of myelogenous leukemic stem cells, giving rise to Ph-positive CML. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.